Exploring vismodegib: A non-surgical breakthrough in the management of advanced periocular basal cell carcinoma
The management of periocular basal cell carcinoma (BCC) is challenging due to its proximity to the eyeball. Vismodegib, a Hedgehog pathway inhibitor, has emerged as a therapeutic option for locally advanced and metastatic BCC. To critically appraise the relevant evidence, we conducted a systematic r...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2024-01-01
|
| Serier: | Cancer Treatment and Research Communications |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S246829422400008X |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
